Human organ chips enable rapid drug repurposing for COVID-19
A Wyss Institute-led collaboration has used the institute’s organ-on-a-chip technology to identify the antimalarial drug amodiaquine as a potent inhibitor of infection with SARS-CoV-2, the virus that causes COVID-19.
Lindsay Brownell •
harvard
May 3, 2021 • ~18 min
May 3, 2021 • ~18 min
New tool developed to study ‘undruggable’ proteins
Researchers at Harvard have designed new, highly selective tools that can add or remove sugars from a protein with no off-target effects, to examine exactly what the sugars are doing and engineer them into new treatments for “undruggable” proteins.
Caitlin McDermott-Murphy •
harvard
April 16, 2021 • ~7 min
April 16, 2021 • ~7 min
/
67